Todas as matérias desta seção, das mais recentes às mais antigas — página 284 de 371.
Medtronic (NYSE:MDT) reported third-quarter fiscal 2026 revenue of $9.017 billion, an increase of 8.7% as reported and 6.0% on an organic basis, surpassing the midpoint of its guidance by 50 basis points and marking the highest enterprise revenue growth in the past 10 quarters.
Fluor (NYSE:FLR) reported a volatile set of full-year 2025 results on Tuesday, as the engineering and construction giant navigated a major legal setback and a dramatic restructuring of its balance sheet.
Valmont Industries (NYSE:VMI) reported fourth-quarter fiscal 2025 net sales of $1.04 billion, essentially flat year over year with a 0.1% increase, as growth in key infrastructure segments was offset by softer demand in certain agricultural markets.
Vulcan Materials Company (NYSE: VMC) reported full-year 2025 adjusted EBITDA of $2.324 billion, an increase of 13% from the prior year, marking a record high for the company.
Danaher (NYSE:DHR) announced it has signed a definitive agreement to acquire all outstanding shares of Masimo Corporation for $180 per share in cash, valuing the deal at approximately $9.9 billion on an enterprise basis.
Harmony Biosciences Holdings (NASDAQ:HRMY) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for WAKIX® (pitolisant) to treat cataplexy in pediatric patients aged six years and older.
Pfizer (NYSE:PFE) today reported positive topline results from Cohort 3 of its pivotal Phase 3 BREAKWATER trial, marking a significant milestone in the treatment of one of the most aggressive forms of colorectal cancer.
SunCoke Energy (NYSE:SXC) reported a full-year 2025 net loss attributable to SXC of $44.2 million, or $0.52 per diluted share, compared with prior-year performance, primarily due to unfavorable one-time items totaling $109.3 million pre-tax ($83.1 million net of tax).
eToro Group (NASDAQ:ETOR) posted full-year 2025 net contribution of $868 million, an increase of 10% from $788 million in 2024, reflecting resilient user engagement and monetization across trading, investing, and crypto activities despite market volatility.
Ceragon Networks (NASDAQ:CRNT) reported fourth-quarter and full-year 2025 results on Tuesday that aligned with its January preliminary update, signaling a year of operational stabilization and a clearing path for double-digit growth in 2026.
Waystar Holding (NASDAQ:WAY) reported fourth-quarter 2025 revenue of $303.5 million, an increase of 24% year over year, contributing to full-year revenue of $1,099.3 million, up 17% from 2024.
Donnelley Financial Solutions (NYSE:DFIN) delivered a decisive fourth-quarter performance on Tuesday, showcasing the financial muscle of its multi-year transition from a legacy commercial print business into a high-margin regulatory software provider.
Watsco (NYSE:WSO) posted full-year 2025 revenues of $7.24 billion, down 5% from the prior year, reflecting headwinds in equipment volumes offset partially by an 11% increase in average domestic selling prices and contributions from parts and supplies.
Hillman Solutions (NASDAQ:HLMN) reported record full-year 2025 net sales of $1.55 billion, an increase of 5.4% from 2024, driven by strength across its fastener, keys, and protective solutions categories, as well as contributions from merchandising innovations and expanded retail partnerships.
Palatin Technologies (NYSE:PTN) reported its fiscal second-quarter 2026 results on Tuesday, marking a critical operational pivot as the biopharmaceutical firm clears financial hurdles and prepares to enter the highly competitive clinical landscape for weight-loss therapies.
Ceva (NASDAQ:CEVA) today announced record fourth-quarter 2025 revenue of $31.3 million, up 7% year over year and 10% sequentially, marking the highest quarterly revenue in the company's history.
NeoGenomics (NASDAQ:NEO) delivered solid fourth-quarter 2025 results, with consolidated revenue increasing 11% year over year to $190 million, driven by robust demand for its oncology-focused diagnostic testing services.
USA Compression Partners (NYSE:USAC) reported record total revenues of $252.5 million for the fourth quarter of 2025, up from $245.9 million in the year-ago period, reflecting continued strength in its contract compression business serving upstream and midstream natural gas producers.
Shutterstock (NYSE:SSTK) reported full-year 2025 revenue of $989.9 million, up 6% from $935.3 million in 2024, marking a record high for the creative platform provider.
Genuine Parts Company (NYSE:GPC) reported fourth-quarter 2025 sales of $6 billion, up 4.1% from the prior year, driven by modest comparable sales growth, contributions from acquisitions, and favorable currency impacts.
Labcorp Holdings (NYSE:LH) reported fourth-quarter 2025 revenue of $3.52 billion, contributing to full-year enterprise revenue of $13.95 billion, up 7.2% from the prior year.
Somnigroup International (NYSE:SGI) reported explosive fourth-quarter growth as the first full year of its $5 billion Mattress Firm acquisition propelled the bedding titan to record sales and a significant expansion of its direct-to-consumer footprint.
Louisiana-Pacific (NYSE:LPX) reported a net loss for the final quarter of 2025, as a significant downturn in the oriented strand board (OSB) market overshadowed continued growth in its high-margin siding business.
Allegion (NYSE:ALLE) reported fourth-quarter and full-year 2025 results on Tuesday, surpassing the $4 billion annual revenue milestone for the first time as the security giant benefits from a surge in electronic lock adoption and a resilient U.S. commercial market.
